End-of-life trajectories of patients with hematological malignancies and patients with advanced solid tumors visiting the emergency department : the need for a proactive integrated care approach

Article indépendant

VERHOEF, Mary-Joanne | DE NIJS, Ellen J. M. | OOTJERS, Claudia S. | FIOCCO, Marta | FOGTELOO, Anne J. | HERINGHAUS, Christian | MARIJNEN, Corrie A. M. | HOREWEG, Nanda | VAN DER LINDEN, Yvette M.

PURPOSE: Patients with hematological malignancies (HM) have more unpredictable disease trajectories compared to patients with advanced solid tumors (STs) and miss opportunities for a palliative care approach. They often undergo intensive disease-directed treatments until the end of life with frequent emergency department (ED) visits and in-hospital deaths. Insight into end-of-life trajectories and quality of end-of-life care can support arranging appropriate care according to patients' wishes. METHOD: Mortality follow-back study to compare of end-of-life trajectories of HM and ST patients who died <3 months after their ED visit. Five indicators based on Earle et al. for quality of end-of-life care were assessed: intensive anticancer treatment <3 months, ED visits <6 months, in-hospital death, death in the intensive care unit (ICU), and in-hospice death. RESULTS: We included 78 HM patients and 420 ST patients, with a median age of 63 years; 35% had Eastern Cooperative Oncology Group performance status 3-4. At the ED, common symptoms were dyspnea (22%), pain (18%), and fever (11%). After ED visit, 91% of HM patients versus 76% of ST patients were hospitalized (P = .001). Median survival was 17 days (95% confidence interval [CI]: 15-19): 15 days in HM patients (95% CI: 10-20) versus 18 days in ST patients (95% CI: 15-21), P = .028. Compared to ST patients, HM patients more often died in hospital (68% vs 30%, P < .0001) and in the ICU or ED (30% vs 3%, P < .0001). CONCLUSION: Because end-of-life care is more aggressive in HM patients compared to ST patients, a proactive integrated care approach with early start of palliative care alongside curative care is warranted. Timely discussions with patients and family about advance care planning and end-of-life choices can avoid inappropriate care at the end of life.

http://dx.doi.org/10.1177/1049909119896533

Voir la revue «The American journal of hospice and palliative care, 37»

Autres numéros de la revue «The American journal of hospice and palliative care»

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Gestion